Mi‐Na Kim
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 58
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 55
- Antifungal resistance and susceptibility 35
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 63
- Endocrinology top 1%
-
- Pneumonia and Respiratory Infections 34
- Fungal Infections and Studies 30
- Mycobacterium research and diagnosis 29
- Pneumocystis jirovecii pneumonia detection and treatment 27
- Co-authors
- Heungsup SungSang‐Ho ChoiJun Hee WooYang Soo KimSang‐Oh LeeSung‐Han KimKyungwon LeeYong Pil Chong
- Journals
- Annals of Laboratory Medicine (39 papers)Diagnostic Microbiology and Infectious Disease (20 papers)Antimicrobial Agents and Chemotherapy (19 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Mi‐Na Kim
315 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Medicine 1.1k
- Infectious Diseases 3.2k
- Clinical Biochemistry 1.1k
- Applied Microbiology and Biotechnology 297
- Endocrinology 436
Countries citing papers authored by Mi‐Na Kim
This map shows the geographic impact of Mi‐Na Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Na Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Na Kim more than expected).
Fields of papers citing papers by Mi‐Na Kim
This network shows the impact of papers produced by Mi‐Na Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Na Kim. The network helps show where Mi‐Na Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mi‐Na Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 11 | |
| 16 | 2019 | 1 | |
| 17 | 2012 | 14 | |
| 18 | 2011 | 68 | |
| 19 | Occurrence and Genotypic Distributions of Plasmid-Mediated AmpC $\beta$ -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Korea | 2002 | 12 |
| 20 | Survey on Changes in Mycobacterial Testing Practicies in Korean Laboratories. | 2001 | 13 |
About Mi‐Na Kim
Mi‐Na Kim is a scholar working on Molecular Medicine, Clinical Biochemistry, Infectious Diseases, Microbiology and Applied Microbiology and Biotechnology, having authored 341 papers that have together received 6.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (63 papers), Antibiotic Resistance in Bacteria (58 papers), Antimicrobial Resistance in Staphylococcus (55 papers), Antifungal resistance and susceptibility (35 papers), Pneumonia and Respiratory Infections (34 papers), Fungal Infections and Studies (30 papers), Mycobacterium research and diagnosis (29 papers) and Pneumocystis jirovecii pneumonia detection and treatment (27 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Infectious Diseases (3.2k citations), Clinical Biochemistry (1.1k citations), Applied Microbiology and Biotechnology (297 citations) and Endocrinology (436 citations). Mi‐Na Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Heungsup Sung, Sang‐Ho Choi, Jun Hee Woo, Yang Soo Kim, Sang‐Oh Lee, Sung‐Han Kim, Kyungwon Lee, Yong Pil Chong, Jin‐Yong Jeong and Jong Hee Shin. Their work appears in journals such as Annals of Laboratory Medicine, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology and Journal of Korean Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.